The Industry-Academia Alliance for Prevalent Disease
Interested in presenting? Apply to Speak →
The "proof of concept" era of gene therapy is now behind us. As we move into 2027, the field stands at a pivotal turning point — shifting from treating rare ultra-orphan diseases to addressing large patient populations suffering from prevalent chronic conditions such as cardiovascular diseases, neurodegenerative disorders, and metabolic syndromes.
Gene Scale 2027 is the premier industry-academia alliance dedicated to solving the complex challenges of scaling gene therapies. This summit focuses on the "Last Mile" — moving from laboratory success to commercial, manufacturable, and reimbursable therapies capable of reaching millions of patients globally.
Strategic Partnerships & Executive Engagement Associate
Get first-look data on In-Vivo CAR-T and Epigenome Editing — the 2027 breakthroughs that make prevalent-disease targets safe and viable.
Move from manual cleanrooms to AI Digital Twins and Closed-Loop Pods — the automated factories of the future.
San Diego is the 2027 hub for viral-vector manufacturing. Connect with the C-suite and VPs of the companies actually building the factories of the future.
Focus: Mastering the molecular toolkit for non-rare, large-scale conditions.
Base and Prime Editing clinical readouts for Hypercholesterolemia and Amyloidosis — how "search-and-replace" technology has eliminated off-target fears.
Case-study slot reserved for accepted faculty. Speaker details will be published after confirmation.
A deep dive into shortcomings of commercialized products vs. emerging mRNA/LNP and biomaterial platforms.
Networking in the Gene-Scale Tech Hall.
New capsid engineering and non-viral ligands for Alzheimer's and Parkinson's — moving from "managing symptoms" to "genetic reversal."
Utilizing CRISPR-off technology for chronic pain and hypertension — without altering the DNA sequence.
Rapid-fire 10-minute presentations on the most recent 2027 clinical results — designed to attract venture-backed startups and PIs.
Focus: Crushing the COGs (Cost of Goods) through AI and Robotics.
Using AI to simulate thousands of batch runs in seconds to optimize yield — moving from "Trial and Error" to "Predictive Bioprocessing."
A technical look at decentralized manufacturing — deploying small-footprint, automated "pods" directly in regional hospitals.
Targeted tables for Manufacturing Leads and CDMOs.
Integrating automated analytical development (ddPCR/NGS) into the production line to eliminate the 3-week QC wait time.
Addressing the 2027 bottleneck: scaling plasmid and LNP production for millions of doses vs. the scarcity of viral vectors.
A high-level debate on the role of robotics in replacing manual cleanroom labour to ensure 2027 cost-viability.
Focus: Regulation, Reimbursement, and Global Scale.
A review of multi-year annuity payments for curative therapies — how payers are handling the shift to Heart Failure populations.
How the FDA and EMA are harmonizing CMC requirements for prevalent-disease trials to speed up 2027 launches.
Open forum with policy makers and VC partners.
CEOs from top biotechs discuss the 5-year roadmap for Cardiovascular Gene Therapy — the industry's next $100B market.
Investment trends for the "post-rare" era — where will the smart money flow in 2027?
Synthesis of the 3-day findings and an announcement of the 2027 objectives to keep delegates engaged year-round.
We're seeking pioneering case studies, fresh clinical data, and scalable manufacturing solutions across all four tracks. Submission deadline: November 15, 2026.
CEO / COO / CTO of Biotech and Pharma seeking asset-level execution strategies.
Directors of Bioprocessing, Quality, and Supply Chain.
PIs and PhDs specializing in Base / Prime editing and non-viral delivery.
VC / PE partners and insurance executives navigating the $3M+ reimbursement landscape.
Three days of science and strategy, set in one of San Diego's most striking conference destinations.
GENE-SCALE 2027 convenes at the Hyatt Regency La Jolla at Aventine — a landmark San Diego venue that pairs light-filled, glass-walled event pavilions with grand ballrooms, set in the heart of La Jolla's Golden Triangle and minutes from the region's leading research institutes and biotech campuses.
3777 La Jolla Village Drive, San Diego, CA 92122
View on Google Maps →
Reserve your place at GENE-SCALE 2027 — March 08–10, San Diego, CA. Limited executive seating.
or request more information
or request more information
Thanks — we've noted your interest. The team will be in touch shortly.
Prefer to talk first? Email narendra.etkela@synerg.events